- |||||||||| LIGHT-PSMA-CART cells / BRL Medicine
Trial completion date, Trial suspension, Trial primary completion date: LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer (clinicaltrials.gov) - Apr 11, 2022
P1, N=12, Suspended,
Trial primary completion date: Nov 2022 --> Nov 2023 Trial completion date: Dec 2022 --> Dec 2023 | Recruiting --> Suspended | Trial primary completion date: Nov 2021 --> Nov 2022
- |||||||||| LIGHT-PSMA-CART cells / BRL Medicine
Trial primary completion date: LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer (clinicaltrials.gov) - Sep 26, 2021
P1, N=12, Recruiting,
Trial completion date: Dec 2022 --> Dec 2023 | Recruiting --> Suspended | Trial primary completion date: Nov 2021 --> Nov 2022 Trial primary completion date: Jul 2021 --> Nov 2021
- |||||||||| LIGHT-PSMA-CART cells / BRL Medicine
Phase classification, Trial completion date, Trial initiation date, Trial primary completion date: LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer (clinicaltrials.gov) - Jul 26, 2020
P1, N=12, Recruiting,
Trial primary completion date: Jul 2021 --> Nov 2021 Phase classification: P1/2 --> P1 | Trial completion date: Aug 2022 --> Dec 2022 | Initiation date: Aug 2019 --> Jul 2020 | Trial primary completion date: Aug 2020 --> Jul 2021
|
